Evidence map›Paper›PMID 33843994›Full record

ArticleThe Journal of antimicrobial chemotherapy2021

The case for precision dosing: medical conservatism does not justify inaction.

Marc H Scheetz, Thomas P Lodise, Kevin J Downes, George Drusano, Michael Neely

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Review
  3. Artificial Intelligence Opportunities to Guide Precision Dosing Strategies.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2024
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Marc H ScheetzDepartment of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University, Downers Grove, IL, USA.ORCID 0000-0002-1091-6130
Thomas P LodiseDepartment of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, NY, USA.
Kevin J DownesDepartment of Pediatrics, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0001-5015-8146
George DrusanoInstitute for Therapeutic Innovation, College of Medicine, University of Florida, Orlando, FL, USA.
Michael NeelyChildren's Hospital Los Angeles and University of Southern California, Los Angeles, CA, USA.
Albany College of Pharmacy and Health Sciences · USChildren's Hospital of Philadelphia · USMidwestern University · USUniversity of Florida · USUniversity of Southern California · US

Funding

Optimizing Vancomycin Therapy in ChildrenK23HD091365 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI DOWNES, KEVIN JAMES · 2018 to 2022
$747k
Quantifying renal injury among the most commonly used clinical antibiotic combinationsR21AI149026 · NIAID · MIDWESTERN UNIVERSITY · PI SCHEETZ, MARC HOWARD · 2020 to 2021
$413k
NIAID NIH HHS R21 AI149026NICHD NIH HHS K23 HD091365
6 · The paper itself

Abstract

The need for precision dosing has been challenged on the basis of insufficient evidence. Herein, we argue that adequate evidence exists to conduct therapeutic drug monitoring (TDM) and precisely target antibiotic exposures. While achievement of any antibiotic concentration does not guarantee efficacy sans toxicity for any single patient, stochastic control optimizes the probability of achieving favourable responses across patients. We argue that variability in targets (such as the organism's MIC) can be considered with models. That is, complexity alone does not relegate the decision-making framework to 'clinician intuition'. We acknowledge the exposure-response relationships are modified by patient-specific factors (other drugs, baseline organ functional status etc.) and describe how precision dosing can inform clinical decision making rather than protocolize it. Finally, we call for randomized, controlled trials; however, we suggest that these trials are not necessary to make TDM standard of care for multiple classes of antibiotics.

Indexed as

Anti-Bacterial AgentsDrug MonitoringHumansAnti-Bacterial Agents

Identifiers

PMID33843994
PMCPMC8212772
OpenAlexW3153665612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.